Mark Lansdown

2.5k total citations
45 papers, 1.8k citations indexed

About

Mark Lansdown is a scholar working on Surgery, Oncology and Genetics. According to data from OpenAlex, Mark Lansdown has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 13 papers in Oncology and 11 papers in Genetics. Recurrent topics in Mark Lansdown's work include Estrogen and related hormone effects (8 papers), Breast Cancer Treatment Studies (8 papers) and Breast Lesions and Carcinomas (6 papers). Mark Lansdown is often cited by papers focused on Estrogen and related hormone effects (8 papers), Breast Cancer Treatment Studies (8 papers) and Breast Lesions and Carcinomas (6 papers). Mark Lansdown collaborates with scholars based in United Kingdom, Italy and Belgium. Mark Lansdown's co-authors include Valerie Speirs, Andrew M. Hanby, P J Carder, Chirag N. Patel, Andrew Scarsbrook, G. Skliris, Sally Lane, Kieran Horgan, Timothy Perren and Ken MacLennan and has published in prestigious journals such as Gut, The Lancet Oncology and British Journal of Cancer.

In The Last Decade

Mark Lansdown

43 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Lansdown United Kingdom 19 711 551 514 428 377 45 1.8k
William P. Peters United States 28 875 1.2× 139 0.3× 561 1.1× 461 1.1× 188 0.5× 68 2.5k
Maria Timofeeva United Kingdom 24 347 0.5× 378 0.7× 797 1.6× 240 0.6× 221 0.6× 67 2.0k
Catharine M. Sturgeon United Kingdom 25 623 0.9× 108 0.2× 735 1.4× 412 1.0× 337 0.9× 73 2.4k
B. Weber France 29 1.6k 2.3× 236 0.4× 686 1.3× 451 1.1× 824 2.2× 97 3.8k
René Baumann France 26 268 0.4× 522 0.9× 225 0.4× 398 0.9× 485 1.3× 90 2.2k
Newton A C S Wong United Kingdom 26 635 0.9× 304 0.6× 557 1.1× 175 0.4× 636 1.7× 87 2.1k
Konstantinos Kontzoglou Greece 28 641 0.9× 142 0.3× 835 1.6× 422 1.0× 761 2.0× 138 2.7k
G. Ferretti Italy 30 1.2k 1.7× 434 0.8× 690 1.3× 579 1.4× 258 0.7× 150 2.7k
Gianfilippo Bertelli United Kingdom 27 1.3k 1.8× 421 0.8× 232 0.5× 563 1.3× 244 0.6× 107 2.2k

Countries citing papers authored by Mark Lansdown

Since Specialization
Citations

This map shows the geographic impact of Mark Lansdown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lansdown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lansdown more than expected).

Fields of papers citing papers by Mark Lansdown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lansdown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lansdown. The network helps show where Mark Lansdown may publish in the future.

Co-authorship network of co-authors of Mark Lansdown

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lansdown. A scholar is included among the top collaborators of Mark Lansdown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lansdown. Mark Lansdown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lansdown, Mark, et al.. (2019). Routine intraoperative neuromonitoring during thyroidectomy: a UK single-institution experience. PubMed. 44(2). 236–238. 2 indexed citations
2.
Fatayer, Hiba, Nisha Sharma, Baek Kim, et al.. (2016). Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatment. European Journal of Surgical Oncology. 42(7). 965–972. 13 indexed citations
3.
Fatayer, Hiba, B. Dall, Nisha Sharma, et al.. (2016). Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression – Implications for the practising oncologist. European Journal of Cancer. 60. 40–48. 53 indexed citations
4.
Rajan, Sreekumar Sundara, Rashmi Verma, Abeer M. Shaaban, et al.. (2013). Palpable Ductal Carcinoma in Situ: Analysis of Radiological and Histological Features of a Large Series With 5-Year Follow-Up. Clinical Breast Cancer. 13(6). 486–491. 13 indexed citations
5.
Rajan, Sreekumar Sundara, Jonathan White, Adam Peckham-Cooper, Sally Lane, & Mark Lansdown. (2012). Management of Palpable but Radiologically Occult Breast Abnormalities. Acta Cytologica. 56(3). 266–270. 3 indexed citations
6.
7.
Milton, Richard, et al.. (2007). Video-assisted mediastinoscopy (VAM) for surgical resection of ectopic parathyroid adenoma. Journal of Cardiothoracic Surgery. 2(1). 41–41. 16 indexed citations
8.
Lansdown, Mark, et al.. (2006). Appendicectomy: Who Performs it, When and How?. Annals of The Royal College of Surgeons of England. 88(6). 530–534. 6 indexed citations
9.
Murphy, Claire, P J Carder, Mark Lansdown, & Valerie Speirs. (2005). Steroid hormone receptor expression in male breast cancer. European Journal of Surgical Oncology. 32(1). 44–47. 36 indexed citations
10.
Duffy, Simon P., Mark Lansdown, Kamaira Philips, et al.. (2005). The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment. Human Reproduction. 21(2). 545–553. 49 indexed citations
11.
12.
Hamady, Zaed, et al.. (2004). Surgical pathological second opinion in thyroid malignancy: impact on patients' management and prognosis. European Journal of Surgical Oncology. 31(1). 74–77. 33 indexed citations
13.
Goyal, Amit, Kieran Horgan, M.W. Kissin, et al.. (2004). Sentinel lymph node biopsy in male breast cancer patients. European Journal of Surgical Oncology. 30(5). 480–483. 51 indexed citations
14.
Speirs, Valerie, P J Carder, Sally Lane, et al.. (2004). Oestrogen receptor β: what it means for patients with breast cancer. The Lancet Oncology. 5(3). 174–181. 105 indexed citations
15.
Hanby, Andrew M., et al.. (2003). Breast cancer cell lines: friend or foe?. Breast Cancer Research. 5(2). 89–95. 237 indexed citations
16.
Skliris, G., Kailas Munot, Sandra Bell, et al.. (2003). Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model. The Journal of Pathology. 201(2). 213–220. 168 indexed citations
17.
Skliris, G., P J Carder, Mark Lansdown, & Valerie Speirs. (2001). Immunohistochemical detection of ERβ in breast cancer: towards more detailed receptor profiling?. British Journal of Cancer. 84(8). 1095–1098. 74 indexed citations
18.
Murchan, P, et al.. (1998). Five years' experience of PAS Port intravenous access system in adult cystic fibrosis. European Respiratory Journal. 12(1). 212–216. 22 indexed citations
19.
Royston, C M S, Mark Lansdown, & W A Brough. (1994). Teaching laparoscopic surgery: the need for guidelines. BMJ. 308(6935). 1023–1025. 48 indexed citations
20.
Lansdown, Mark, et al.. (1990). High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma.. Gut. 31(9). 977–983. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William P. Peters Breakdown of academic impact, for papers by Maria Timofeeva Breakdown of academic impact, for papers by Catharine M. Sturgeon Breakdown of academic impact, for papers by B. Weber Breakdown of academic impact, for papers by René Baumann Breakdown of academic impact, for papers by Newton A C S Wong Breakdown of academic impact, for papers by Konstantinos Kontzoglou Breakdown of academic impact, for papers by G. Ferretti Breakdown of academic impact, for papers by Gianfilippo Bertelli
Rankless by CCL
2026